Bay City Capital

Bay City Capital

03 Mar 2020
$100,500,000
Venture capital (Series B)

Xilio Therapeutics Raises $100.5M in Series B Financing

FinSMEs
+1
04 Jan 2018
$20,300,000
Venture capital (Series B)

Oculis raises $20.3m Series B round to advance treatment for Ophthalmic Diseases

Norðurskautið
+1
25 Jul 2017

Kezar adds $50M to its funding tally for immunoproteasome drug

FierceBiotech
+1
18 Jul 2017
$50,000,000
Venture capital (Series C)

Menlo Therapeutics Raises $50M in Series C Financing

FinSMEs
+1
25 Jul 2016

Pfizer, NEA-backed rare disease startup bumps up Series A to $42M

FierceBiotech
+1
19 Aug 2014
$51,000,000
Venture capital (Series C)
06 Jan 2014
$6,800,000
Venture capital (Series A)
09 Jul 2013
11 Jun 2013
$35,000,000
Venture capital (Series B)
20 May 2013
$12,000,000
Post-IPO equity
13 Mar 2013
07 Mar 2013
$48,000,000
Venture capital (Series C)
20 Oct 2011
$42,000,000
Venture capital (Series A)
21 Jun 2011
07 Oct 2010
15 Jan 2010
19 Oct 2009